Share Print

Funding Opportunities in Cancer Research



For assistance with funding, contact: 
Paige Isom, Research Adminstrator,
Funding and Awards
Phone: 314-454-8980




Siteman Cancer Center — Internal

Barnes-Jewish Foundation

Deadline Funding Opportunity Sponsor Amount Description
Nov. 10, 2015 NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) NCI $275,000 over 2 years This R21 supports the development of new research activities in all areas of cancer research by encouraging exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).

Nov. 13, 2015

NEW: Stand Up To Cancer (SU2C) Innovative Research Grants

Stand Up To Cancer

$750,000 over 3 years

The SU2C Innovative Research Grants will fund novel, high-risk, high-reward cancer research proposals that have significant potential for translational application and hold great promise for advancing SU2C’s overarching goal of improving and saving the lives of patients. Proposals may focus on any discipline within basic, translational, or clinical cancer research, provided that these criteria are met. Tenure-track investigators who started their first independent position no more than 7 years ago (i.e., on or after June 30, 2009) are eligible to apply. Projects that are currently supported by NIH R01 grants, or the equivalent, will not be accepted.


NCCN Foundation Young Investigator Award NCCN Foundation $150,000 over 2 years This Foundation invites proposals from young investigators with innovative ideas and an interest in the development and evaluation of the NCCN clinical practice guidelines.  Research projects may focus on guideline application in decision-making and formation of policies related to drug access and utilization, biologicals, devices, diagnostics, medical economics, new technologies, clinical trials, and cancer treatment procedures.


Damon Runyon Cancer Clinical Investigator Award  Damon Runyon Cancer Research Foundation $450,000 over 3 years Washington University has been invited to nominate three candidates for the Damon Runyon Clinical Investigator Award from the Damon Runyon Cancer Research Foundation. This award is intended to provide outstanding young physicians with the resources and training structure essential to becoming independent clinical investigators.


V Foundation Scholar Award V Foundation for Cancer Research $200,000 over 2 years One candidate from WU allowed. Prestigious young investigator awards that support the independent research of outstanding individuals whose work in basic cancer research has significant potential to contribute to a cure for cancer. Must have complete 2 years of fellowship training; must hold tenured track faculty position - within the first five years of appointment; MD or PhD earned no more than 10 years ago; must not have been promoted to associate professor.
INTERNAL COMPETITION: Nov. 16, 2015 Rita Allen Foundation Scholar Awards Program Rita Allen Foundation $550,000 over 5 years The Rita Allen Foundation Scholars Program is designed to support young independent investigators who are leaders in biomedical science and whose research focus is on areas that are of global concern in the fields of cancer, neuroscience, and immunology. The Program provides grants to selected academic institutions that are leaders in medical research to support the independent research of outstanding individuals who are in the early stages of their careers.
Dec. 1, 2015 
Damon Runyon Physician-Scientist Training Award Damon Runyon Cancer Research Foundation $460,000 over 4 years; retirement of up to $100,000  of medical school debt This program is designed to recruit outstanding U.S. Specialty Board-eligible physicians (MDs only) into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their clinical training.

Jan. 6, 2016

NEW: Alvin J. Siteman Cancer Research Fund

Alvin J. Siteman

$300,000/year for up to 2 years

Intended for both short-term projects and significant major initiatives. Targeted particularly for innovative, translational research programs that have the promise of transforming cancer prevention, diagnosis, or treatment, especially those that are unlikely to receive funding from traditional sources at this stage. The fund will be a resource to catalyze fruitful research progress that will ultimately attract additional foundation, corporate, or federal research support.

Feb. 12, 2016

NEW: Cancer Research UK Grand Challenge Awards 

Cancer Research UK


up to £20M over 5 years


Grand Challenge awards are the most ambitious cancer research grants in the world. They’re intended to catalyze a revolution in how we prevent, diagnose, and treat cancer by bringing together the brightest minds around the globe, providing the freedom to undertake innovative, game-changing research to solve one of seven Grand Challenges:

1) Develop vaccines to prevent non-viral cancers 2) Eradicate EBV-induced cancers from the world 3) Discover how unusual patterns of mutation are induced by different cancer-causing events 4) Distinguish between lethal cancers that need treating, and non-lethal cancers that don't 5) Find a way of mapping tumors at the molecular and cellular level 6) Develop innovative approaches to target the cancer super-controller MYC 7) Deliver biologically active macromolecules to any and all cells in the body